| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -5.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, QNRX returned -22.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -61.4% |
| 1 year | -22.6% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $976,500.00 (Oct 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in QNRX would be worth today ›No. Quoin Pharmaceuticals, Ltd. has not paid a dividend in the past 12 months.
Quoin Pharmaceuticals, Ltd. stock trades on NASDAQ under the ticker symbol QNRX.
Quoin Pharmaceuticals, Ltd. is part of the Healthcare sector.
Quoin Pharmaceuticals, Ltd. has a market cap of 11.19M USD, based on the latest quote.
